Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 16, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ross Osborn Reiterated (VNRX) at Buy and Held Target at $2.5 on, May 16th, 2024
Ross Osborn of Cantor Fitzgerald, Reiterated "VolitionRx Limited" (VNRX) at Buy and Held Target at $2.5 on, May 16th, 2024.
Ross has made no other calls on VNRX in the last 4 months.
There is 1 other peer that has a rating on VNRX. Out of the 1 peers that are also analyzing VNRX, 0 agree with Ross's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ross
- Tim Moore of "EF Hutton" Maintained at Strong Buy and Held Target at $4.5 on, Tuesday, May 14th, 2024
